Searched for
ERIS LIFESCIENCES SHARE
Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details here- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check details
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...08 May, 2026, 08.54 AM IST
- Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in IndiaShares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco...24 Feb, 2026, 04.31 PM IST
- Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...25 Nov, 2025, 08.31 AM IST
- Eris Lifesciences' unit gets Brazil health regulator nodEris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...25 Aug, 2025, 02.40 PM IST
- Eris Lifesciences eyes ‘good’ share in semaglutide generics, says COOEris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March 2026. Eris aims ...05 Aug, 2025, 10.50 PM IST
- Eris Lifesciences Q1 Results: Net dips 4.5% YoY at Rs 89 croreEris Lifesciences on Friday said its consolidated profit after tax declined by 4.5 per cent year on year to Rs 89 crore for the quarter end...02 Aug, 2024, 08.19 PM IST
- Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 crEris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parent...13 Feb, 2024, 07.21 PM IST
- Buy Eris Lifesciences, target price Rs 710: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 7871.82 Crore) operating in Pharmaceutica...17 Mar, 2023, 10.35 AM IST
- Eris Lifesciences acquires 9 dermatology brands from Dr Reddy's for Rs 275 crThe transaction will be financed through borrowings and will achieve financial closure in the next few days, the drug firm said. In a separ...16 Mar, 2023, 06.06 PM IST
- Buy Eris Lifesciences, target price Rs 850: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8921.10 Crore) operating in Pharmace...08 Jul, 2022, 09.49 AM IST
- Eris Lifesciences jumps 10% as investors cheer JV with MJ BiopharmThe JV, dubbed Eris Biopharm, would be in the ratio of 70:30, with Eris holding a 70 per cent stake.06 Dec, 2021, 11.10 AM IST
- Eris Lifesciences Q3 results: Net profit up 42% at Rs 90 croreConsolidated total revenue from operations of the company stood at Rs 310.42 crore for the quarter under consideration. It was Rs 266.39 cr...28 Jan, 2021, 03.08 PM IST
- Eris Lifesciences Q2 results: Net profit up 16% at Rs 108 crTotal revenue from operations stood at Rs 329.99 crore for the quarter under consideration. It was Rs 284.79 crore for the same period year...03 Nov, 2020, 05.30 PM IST
- Buy Eris Lifesciences, target price Rs 690: Haitong SecuritiesThe brokerage values Eris at a 20 per cent premium to its mid-cap peers.21 Apr, 2020, 08.24 AM IST
- Accumulate Eris Lifesciences, target Rs 704: Prabhudas LilladherAccumulate Eris Lifesciences Ltd. at a price target of Rs 704.07 Dec, 2018, 05.08 PM IST
- Eris Lifesciences, Shasun Strides shares rise on Rs 500 crore dealThe India branded generics business being divested by Strides had sales of Rs 181 core FY 2017, the statement said.20 Nov, 2017, 04.08 PM IST
- Eris Lifesciences sets IPO price band in Rs 600-603 rangeThe shareholders of the company plans to sell 28,875,000 equity shares.09 Jun, 2017, 03.43 PM IST
Load More
